Stock chart
Ticker: ADVM Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
2024-02-09 2024-02-07 B Purchase

Scopa James Paul

Non-Executive Director
100,000 +inf%
1.35
135,000 USD
100,000 +inf% 1.35 135,000 USD
2024-02-09 2024-02-07 B Purchase

Lupher, Jr. Mark L.

Non-Executive Director
130,000 +inf%
1.35
175,500 USD
130,000 +inf% 1.35 175,500 USD
2023-06-09 2023-06-07 B Purchase

Rubinstein Linda M

Chief Financial Officer

Officer
100,000 +inf%
1.45
145,490 USD
100,000 +inf% 1.45 145,490 USD
2022-05-24 2022-05-23 B Purchase

Seyedkazemi Setareh

Chief Development Officer

Officer
20,000 +3333.3%
0.84
16,800 USD
20,000 +3333.3% 0.84 16,800 USD
2022-05-19 2022-05-17 B Purchase

Beckman Richard

Chief Medical Officer

Officer
10,000 +inf%
0.82
8,228 USD
10,000 +inf% 0.82 8,228 USD
2022-05-17 2022-05-17 B Purchase

D'Souza Rupert

Chief Financial Officer

Officer
10,000 +92.2%
0.83
8,272 USD
10,000 +92.2% 0.83 8,272 USD
2022-05-18 2022-05-16 B Purchase

Svoronos Dawn

Non-Executive Director
30,000 +150.0%
0.85
25,578 USD
30,000 +150.0% 0.85 25,578 USD
2022-05-17 2022-05-13 B Purchase

D'Souza Rupert

Chief Financial Officer

Officer
10,000 +1176.5%
0.86
8,585 USD
10,000 +1176.5% 0.86 8,585 USD
2022-04-22 2022-04-20 B Purchase

Fischer Laurent

CEO, President and Director

Executive Director
25,000 +3.4%
1.11
27,800 USD
25,000 +3.4% 1.11 27,800 USD
2022-04-20 2022-04-19 B Purchase

Soparkar Peter

See Remarks section

Officer
21,750 +8.4%
1.14
24,795 USD
21,750 +8.4% 1.14 24,795 USD
2022-04-20 2022-04-19 B Purchase

Soparkar Peter

See Remarks section

Officer
175 +0.1%
1.14
199 USD
175 +0.1% 1.14 199 USD
2021-12-10 2021-12-09 B Purchase

Fischer Laurent

CEO, President and Director

Executive Director
14,323 +2.0%
1.85
26,498 USD
14,323 +2.0% 1.85 26,498 USD
2021-12-10 2021-12-08 PP Planned purchase

Fischer Laurent

CEO, President and Director

Executive Director
10,677 +1.5%
1.79
19,112 USD
10,677 +1.5% 1.79 19,112 USD
2021-12-10 2021-12-08 PP Planned purchase

Soparkar Peter

See Remarks section

Officer
25,000 +10.7%
1.91
47,750 USD
25,000 +10.7% 1.91 47,750 USD
2021-11-17 2021-11-15 S Sale

Scopa James Paul

Non-Executive Director
50,000 -93.7%
2.18
109,000 USD
50,000 -93.7% 2.18 109,000 USD
2021-10-04 2021-09-30 S Sale

Clark Julie

Chief Medical Officer

Officer
4,766 -2.8%
2.17
10,342 USD
4,766 -2.8% 2.17 10,342 USD
2021-04-01 2021-03-31 B Purchase

Svoronos Dawn

Non-Executive Director
20,000 +inf%
10.02
200,338 USD
20,000 +inf% 10.02 200,338 USD
2021-03-24 2021-03-24 B Purchase

Machado Patrick

Non-Executive Director
10,000 +12.8%
9.92
99,196 USD
10,000 +12.8% 9.92 99,196 USD
2021-03-24 2021-03-24 B Purchase

Fischer Laurent

CEO and Director

Executive Director
10,000 +61.4%
9.88
98,780 USD
10,000 +61.4% 9.88 98,780 USD
2021-02-11 2021-02-09 S Sale

PATTERSON LEONE D

President and CFO

Officer
62 -0.1%
14.14
877 USD
62 -0.1% 14.14 877 USD
2021-02-11 2021-02-09 S Sale

PATTERSON LEONE D

President and CFO

Officer
12,471 -11.3%
14.10
175,841 USD
12,471 -11.3% 14.10 175,841 USD
2021-01-19 2021-01-15 B Purchase

Machado Patrick

Non-Executive Director
10,000 +14.7%
11.52
115,174 USD
10,000 +14.7% 11.52 115,174 USD
2021-01-19 2021-01-15 B Purchase

Fischer Laurent

CEO and Director

Executive Director
8,600 +111.8%
11.53
99,191 USD
8,600 +111.8% 11.53 99,191 USD
2020-08-19 2020-08-17 PP Planned purchase

Soparkar Peter

Chief Legal Officer

Officer
7,692 +256.4%
13.00
99,996 USD
7,692 +256.4% 13.00 99,996 USD
2020-08-19 2020-08-17 B Purchase

Fischer Laurent

CEO and Director

Executive Director
7,692 +inf%
13.00
99,996 USD
7,692 +inf% 13.00 99,996 USD
2020-07-22 2020-07-20 PS Planned sale

Gasmi Mehdi

Non-Executive Director
5,000 -1.8%
17.60
87,978 USD
5,000 -1.8% 17.60 87,978 USD
2020-06-23 2020-06-22 PS Planned sale

Gasmi Mehdi

Non-Executive Director
23,605 -7.9%
25.06
591,617 USD
23,605 -7.9% 25.06 591,617 USD
2020-06-18 2020-06-18 PS Planned sale

Gasmi Mehdi

Non-Executive Director
11,127 -3.9%
25.01
278,329 USD
11,127 -3.9% 25.01 278,329 USD
2020-06-18 2020-06-17 PS Planned sale

Gasmi Mehdi

Non-Executive Director
268 -0.1%
25.01
6,703 USD
268 -0.1% 25.01 6,703 USD
2020-06-17 2020-06-16 S Sale

PATTERSON LEONE D

President

Officer
13,171 -10.7%
24.68
325,060 USD
13,171 -10.7% 24.68 325,060 USD
2020-06-17 2020-06-15 PS Planned sale

Gasmi Mehdi

Non-Executive Director
159 -0.1%
23.59
3,751 USD
159 -0.1% 23.59 3,751 USD
2020-06-17 2020-06-15 PS Planned sale

Gasmi Mehdi

Non-Executive Director
3,425 -1.2%
23.00
78,787 USD
3,425 -1.2% 23.00 78,787 USD
2020-06-17 2020-06-15 PS Planned sale

Gasmi Mehdi

Non-Executive Director
1,416 -0.5%
21.93
31,047 USD
1,416 -0.5% 21.93 31,047 USD
2020-06-17 2020-06-15 PS Planned sale

Gasmi Mehdi

Non-Executive Director
5,000 -1.8%
21.01
105,042 USD
5,000 -1.8% 21.01 105,042 USD
2020-05-22 2020-05-20 PS Planned sale

Gasmi Mehdi

Non-Executive Director
1,401 -0.5%
20.01
28,030 USD
1,401 -0.5% 20.01 28,030 USD
2020-05-20 2020-05-18 PS Planned sale

Gasmi Mehdi

Non-Executive Director
300 -0.1%
19.03
5,709 USD
300 -0.1% 19.03 5,709 USD
2020-05-20 2020-05-18 PS Planned sale

Gasmi Mehdi

Non-Executive Director
4,700 -1.7%
18.11
85,124 USD
4,700 -1.7% 18.11 85,124 USD
2020-05-20 2020-05-06 PS Planned sale

Gasmi Mehdi

Non-Executive Director
25,000 -8.3%
20.03
500,668 USD
25,000 -8.3% 20.03 500,668 USD
2020-05-08 2020-05-06 PS Planned sale

PATTERSON LEONE D

CEO, President and Director

Executive Director
20,000 -13.9%
20.02
400,400 USD
20,000 -13.9% 20.02 400,400 USD
2020-05-20 2020-05-05 PS Planned sale

Gasmi Mehdi

Non-Executive Director
10,000 -3.5%
16.26
162,573 USD
10,000 -3.5% 16.26 162,573 USD
2020-03-25 2020-03-20 PS Planned sale

PATTERSON LEONE D

CEO, President and Director

Executive Director
39,526 -24.3%
10.17
401,908 USD
39,526 -24.3% 10.17 401,908 USD
2020-03-18 2020-03-17 PS Planned sale

PATTERSON LEONE D

CEO, President and Director

Executive Director
474 -0.3%
10.02
4,749 USD
474 -0.3% 10.02 4,749 USD
2020-02-20 2020-02-18 PS Planned sale

Gasmi Mehdi

Non-Executive Director
5,000 -1.9%
16.23
81,156 USD
5,000 -1.9% 16.23 81,156 USD
2020-02-14 2020-02-14 B Purchase

Scopa James Paul

Non-Executive Director
10,000 +50.0%
13.75
137,500 USD
10,000 +50.0% 13.75 137,500 USD
2020-02-14 2020-02-12 PS Planned sale

Gasmi Mehdi

Non-Executive Director
10,000 -3.7%
15.07
150,690 USD
10,000 -3.7% 15.07 150,690 USD
2019-12-26 2019-12-23 PS Planned sale

PATTERSON LEONE D

CEO, President and Director

Executive Director
40,000 -14.9%
10.72
428,800 USD
40,000 -14.9% 10.72 428,800 USD
2019-05-06 2019-05-06 B Purchase

Scopa James Paul

Non-Executive Director
20,000 +inf%
6.71
134,200 USD
20,000 +inf% 6.71 134,200 USD
2015-06-17 2015-06-15 PS Planned sale

Gasmi Mehdi

SVP,Pharmaceutical Development

Officer
500 -6.7%
39.86
19,931 USD
500 -6.7% 39.86 19,931 USD
2015-06-15 2015-06-12 PS Planned sale

Bain Linda

Chief Financial Officer

Officer
3,500 -28.0%
39.94
139,795 USD
3,500 -28.0% 39.94 139,795 USD
2015-06-11 2015-06-10 PS Planned sale

Chalberg Thomas W.

Chief Executive Officer

Executive Director
6,995 -2.6%
38.90
272,123 USD
6,995 -2.6% 38.90 272,123 USD
2015-06-11 2015-06-10 PS Planned sale

Chalberg Thomas W.

Chief Executive Officer

Executive Director
12,970 -4.6%
38.04
493,339 USD
12,970 -4.6% 38.04 493,339 USD
2015-06-11 2015-06-10 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
600 -0.1%
39.91
23,948 USD
600 -0.1% 39.91 23,948 USD
2015-06-11 2015-06-09 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
200 -0.0%
37.35
7,470 USD
200 -0.0% 37.35 7,470 USD
2015-06-11 2015-06-09 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
7,000 -1.3%
36.20
253,402 USD
7,000 -1.3% 36.20 253,402 USD
2015-06-10 2015-06-08 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
82 -1.2%
39.88
3,270 USD
82 -1.2% 39.88 3,270 USD
2015-06-10 2015-06-08 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
183 -2.5%
38.95
7,128 USD
183 -2.5% 38.95 7,128 USD
2015-06-10 2015-06-08 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
235 -3.1%
37.97
8,923 USD
235 -3.1% 37.97 8,923 USD
2015-06-10 2015-06-08 PS Planned sale

Wachter Paul

Non-Executive Director
176 -0.5%
39.88
7,019 USD
176 -0.5% 39.88 7,019 USD
2015-06-10 2015-06-08 PS Planned sale

Wachter Paul

Non-Executive Director
475 -1.2%
38.96
18,505 USD
475 -1.2% 38.96 18,505 USD
2015-06-05 2015-06-04 PS Planned sale

Hull Hans

SVP, Business Operations

Officer
2,000 -15.0%
37.64
75,283 USD
2,000 -15.0% 37.64 75,283 USD
2015-06-02 2015-06-01 PS Planned sale

Schwartz Steven Daniel

Non-Executive Director
3,093 -0.8%
36.81
113,854 USD
3,093 -0.8% 36.81 113,854 USD
2015-06-02 2015-06-01 PS Planned sale

Wachter Paul

Non-Executive Director
210 -0.5%
36.81
7,730 USD
210 -0.5% 36.81 7,730 USD
2015-05-29 2015-05-28 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
500 -6.7%
38.02
19,009 USD
500 -6.7% 38.02 19,009 USD
2015-05-27 2015-05-26 PS Planned sale

Wachter Paul

Non-Executive Director
102 -0.2%
38.30
3,906 USD
102 -0.2% 38.30 3,906 USD
2015-05-27 2015-05-26 PS Planned sale

Wachter Paul

Non-Executive Director
304 -0.7%
37.59
11,428 USD
304 -0.7% 37.59 11,428 USD
2015-05-22 2015-05-22 PS Planned sale

Schwartz Steven Daniel

Non-Executive Director
5,196 -1.3%
38.88
202,043 USD
5,196 -1.3% 38.88 202,043 USD
2015-05-22 2015-05-21 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
500 -6.7%
38.87
19,435 USD
500 -6.7% 38.87 19,435 USD
2015-05-21 2015-05-19 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
1,000 -8.7%
36.91
36,911 USD
1,000 -8.7% 36.91 36,911 USD
2015-05-21 2015-05-19 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
1,000 -8.7%
36.91
36,911 USD
1,000 -8.7% 36.91 36,911 USD
2015-05-18 2015-05-15 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
4,525 -0.8%
36.00
162,886 USD
4,525 -0.8% 36.00 162,886 USD
2015-05-15 2015-05-14 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
500 -6.7%
35.31
17,656 USD
500 -6.7% 35.31 17,656 USD
2015-05-13 2015-05-13 PS Planned sale

Bain Linda

Chief Financial Officer

Officer
285 -3.1%
34.94
9,959 USD
285 -3.1% 34.94 9,959 USD
2015-05-12 2015-05-11 PS Planned sale

Bain Linda

Chief Financial Officer

Officer
715 -7.4%
34.91
24,964 USD
715 -7.4% 34.91 24,964 USD
2015-05-12 2015-05-11 PS Planned sale

Wachter Paul

Non-Executive Director
132 -0.3%
34.29
4,527 USD
132 -0.3% 34.29 4,527 USD
2015-05-12 2015-05-11 PS Planned sale

Wachter Paul

Non-Executive Director
552 -1.3%
33.70
18,604 USD
552 -1.3% 33.70 18,604 USD